Biochemical characterization of plasma-derived tissue factor pathway inhibitor: post-translational modification of free, full-length form with particular reference to the sugar chain.

Mori, Y; Hamuro, T; Nakashima, T; Hamamoto, T; Natsuka, S; Hase, S; Iwanaga, S

Mori, Y; Hamuro, T; Nakashima, T; Hamamoto, T; Natsuka, S; Hase, S; Iwanaga, S.

Affiliation

Mori Y; Therapeutic Protein Products Research Department, The Chemo-Sero-Therapeutic Research Institute, KAKETSUKEN, Kumamoto, Japan.

J Thromb Haemost ; 7(1): 111-20, 2009 Jan.

Article in En | MEDLINE | ID: mdl-19017259

Subject(s)

Carbohydrates/analysis; Lipoproteins/chemistry; Protein Processing, Post-Translational; Chromatography; Glycoproteins/analysis; Humans; Lipoproteins/blood; Lipoproteins/isolation & purification; Phosphorylation; Protease Inhibitors

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carbohydrates / Protein Processing, Post-Translational / Lipoproteins Limits: Humans Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2009 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google